QuantuMDx’s Q-POC™ Platform Shortlisted for SelectScience Clinical Scientists’ Choice Awards
NEWCASTLE UPON TYNE, UK, [17 June 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of transformational Point-of-Need diagnostics, is pleased to announce that Q-POC™ has made the SelectScientists’ Choice Awards shortlist for the Best New Clinical Product of 2021. The…
Read More